Evoke Pharma Inc


Evoke Pharma Pops 86% In Pre-Market On FDA Approval Of Gimoti Nasal Spray

Evoke Pharma (EVOK) shares leaped 86% in pre-market trading after the U.S.

Evoke Pharma Inc (EVOK) Shares Skyrocket as Gimoti Gets Closer to FDA Approval

Evoke Pharma Inc (NASDAQ:EVOK) investors have a smile on their faces Wednesday morning, after the drug maker announced that it has received a letter …

Company Update (NASDAQ:EVOK): Evoke Pharma Inc Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti

Evoke Pharma Inc (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, today announced that it has completed a pre‑New Drug …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts